At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 38 enrolled
Drug / intervention
refined indigo naturalis ointment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety Comparison Between Refined and Crude Indigo Naturalis Ointment in the Treatment of Psoriatic Vulgaris
In Brief
A Phase 2 clinical trial evaluating refined indigo naturalis ointment and crude indigo naturalis ointment for Psoriasis Vulgaris. Completed, enrolled 38 participants across 1 site.
Detailed Summary
To compare the efficacy and safety of refined indigo naturalis ointment with that of crude ointment in treating psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis Vulgaris
CountriesTaiwan
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedDec 2009
Primary CompletionDec 2010
TodayJul 2026
First PostedDec 1, 2009
Enrollment StartNov 1, 2009
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.6 years ago
Interventions
refined indigo naturalis ointmentdrug
The patients applied either refined oil extract or crude indigo naturalis ointmnet topically to each of two bilaterally symmetrical psoriatic plaque lesions for 8 weeks.
crude indigo naturalis ointmentdrug
The patients applied either refined oil extract or crude indigo naturalis ointmnet topically to each of two bilaterally symmetrical psoriatic plaque lesions for 8 weeks.